CCL2 and obesity disorder: Hypertrophy of adipocytes in obesity leads to the development of hypoxia promoting the activation of inflammatory mediators including monocyte chemotactic protein-1 that attracts immune cells and macrophages in adipose tissue (Litwin and Kułaga, 2021).